Rapid Covalent Labeling of Membrane Proteins on Living Cells Using a Nanobody-Epitope Tag Pair.
Chino C CabaltejaShivani SachdevRoss W ChelohaPublished in: Bioconjugate chemistry (2022)
Synthetic molecules that form a covalent bond upon binding to a targeted biomolecule (proximity-induced reactivity) are the subject of intense biomedical interest for the unique pharmacological properties imparted by irreversible binding. However, off-target covalent labeling and the lack of molecules with sufficient specificity limit more widespread applications. We describe the first example of a cross-linking platform that uses a synthetic peptide epitope and a single domain antibody (or nanobody) pair to form a covalent linkage rapidly and specifically. The rate of the cross-linking reaction between peptide and nanobody is faster than most other biocompatible cross-linking reactions, and it can be used to label live cells expressing receptor-nanobody fusions. The rapid kinetics of this system allowed us to probe the consequences on signaling for ligand cross-linking to the A2A-adenosine receptor. Our method may be generally useful to site-specifically link synthetic molecules to receptors on mammalian cell surfaces.
Keyphrases
- living cells
- fluorescent probe
- induced apoptosis
- single molecule
- cell cycle arrest
- single cell
- binding protein
- cell therapy
- monoclonal antibody
- genome wide
- gene expression
- escherichia coli
- high glucose
- staphylococcus aureus
- cancer therapy
- cell death
- biofilm formation
- pseudomonas aeruginosa
- cystic fibrosis
- cell proliferation
- transcription factor
- dna binding
- hepatitis c virus
- stress induced